Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACHO: Nasal Allergen Challenge in Allergic Asthma
NCT03431961Unknown
- Start
- Mar 2018
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of triamcinolone acetonide in allergic asthma (2 cohorts). Primary endpoint: Cellular inflammation. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT03431961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431961.